JB
KYNB

Julian Baker’s Kyntra Bio KYNB Stock Holding History

Julian Baker’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-9,523
Closed -$643K – 104
2023
Q2 		$643K Sell
9,523
-95,972
-91% -$39.7M ﹤0.01% 101
2023
Q1 		$49.2M Buy
105,495
+50,487
+92% +$26.7M 0.27% 22
2022
Q4 		$22M Buy
55,008
+22,379
+69% +$8.57M 0.13% 39
2022
Q3 		$10.6M Hold
32,629
– – 0.07% 61
2022
Q2 		$8.61M Buy
32,629
+9,359
+40% +$2.39M 0.05% 67
2022
Q1 		$6.99M Buy
23,270
+64
+0.3% +$22.3K 0.04% 77
2021
Q4 		$8.18M Buy
+23,206
New +$7.23M 0.04% 82

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Julian Baker's KYNB Position: Q3 2023 in Review

Julian Baker sold out of Kyntra Bio (KYNB) in Q3 2023, closing a stake of 9,523 shares — an estimated $643K sold.

Julian Baker first reported a position in KYNB in Q4 2021 and held it in 7 quarters. The position peaked at $49.2M in Q1 2023. 110 funds tracked by Wall St. Rank hold KYNB as of Q3 2023.

  • Julian Baker reported no remaining Kyntra Bio position as of Q3 2023 after selling out during the quarter.
  • Julian Baker sold 9,523 Kyntra Bio shares in Q3 2023, an estimated $643K.
  • Julian Baker first reported a position in Kyntra Bio in Q4 2021 and held it in 7 quarters.
  • Julian Baker's Kyntra Bio position peaked at $49.2M in Q1 2023.
  • 110 funds tracked by Wall St. Rank held Kyntra Bio as of Q3 2023.

Based on Baker Bros. Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.